George G Nomikos

George G Nomikos

Plus aucun poste en cours
Health Technology
Consumer Services

Profil

George G Nomikos worked as a Scientific Director-Scientific Affairs at Amgen, Inc. from 2006 to 2007.
He also served as a Director-Scientific Affairs at Cynapsus Therapeutics, Inc. He was a Research Scientist-Neuroscience Discovery at Eli Lilly & Co. from 1998 to 2006.
Additionally, he worked as an Associate Professor at Karolinska Institutet.
Currently, he is the SVP-Medical & Clinical Science at Scholar Rock Holding Corp.
from 2019 to 2022.
He will be serving as the Chief Medical Officer at Lipocine, Inc. starting from 2022 to 2023.
Dr. Nomikos holds a doctorate degree from the University of British Columbia and the National & Kapodistrian University of Athens, which he received in 1987.

Anciens postes connus de George G Nomikos

SociétésPosteFin
LIPOCINE INC. Directeur Technique/Scientifique/R&D 01/04/2023
SCHOLAR ROCK HOLDING CORPORATION Directeur Technique/Scientifique/R&D 02/11/2022
AMGEN INC. Corporate Officer/Principal 01/10/2007
ELI LILLY AND COMPANY Corporate Officer/Principal 01/01/2006
Corporate Officer/Principal -
Voir l'expérience en détail de George G Nomikos

Formation de George G Nomikos

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

88

Relations au 1er degré

8

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées8

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Consumer Services

Health Technology

Health Technology

  1. Bourse
  2. Insiders
  3. George G Nomikos
DERNIÈRES HEURES | -40% : Les Meilleurs Outils Réservés aux Abonnés pour Identifier les Meilleurs Investissements de Demain !
j
:
:
PROFITEZ-EN MAINTENANT
🔇